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Abstract
Introduction: The aim of study is determining the cost-effectiveness of detection
analysis in the presence of exceptional patients who have mild semen disorders,
and beware of unnecessary varicocele repairs; and to ascertain whether patients
with clinical varicocele should undergo Y chromosome (Yq) microdeletion analysis
as a routine procedure.
Material and methods: Varicocele with reflux was diagnosed in 51 male patients
with subfertility symptoms upon physical examination (PE), confirmed by scrotal
colour-Doppler ultrasound (CDU). After cytogenetic examination, Yq micro  -
deletion analysis was performed on the peripheral blood samples using Promega
Y Chromosome Deletion Detection System Version 2. Varicocele repair was
performed under general anaesthesia with optical magnification (3-fold) through
a subinguinal approach.
Results: The mean age of the patients was 27.9. Values of semen concentration
ranged from 0 to 72 million/ml, motility from 0 to 65% (A + B) and Kruger from
0% to 18%. The PE revealed normal size and consistency in the bilateral testicles.
All patients were cytogenetically normal. However, Yq microdeletion was
detected in 2 patients, 1 with mild oligoteratozoospermia and partial AZFb
deletion (sY121) and the second patient with severe oligozoospermia and partial
AZFc deletion (sY254 and sY255), and they were not subjected to varico  -
celectomy. 
Conclusions: The routine performance of pre-operative Yq microdeletion analysis
in patients with clinical varicocele does not seem to be cost-effective but the
omission of patients with mild oligozoospermia would have subjected them to
an unnecessary varicocelectomy and/or further ICSI applications and also would
have caused the failure of referral for genetic counselling.
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Introduction
Subfertility is defined by the World Health Organization (WHO) as failure
to conceive over 12 months of unprotected frequent intercourse and affects
approximately 15% of couples; among these half are male-related [1].
Varicocele is a physical abnormality present in 11% of adult males [2] and
in 25% of those with abnormal semen analysis [3]. Varicocelectomy, 
in general, brings an improvement in semen parameters in 50-80% of
patients and pregnancy rates vary from 20% to 69% [4]. 
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One of the most significant pathogenetic defects
associated with male infertility is microdeletions of
the long arm of Yq. 13% of azoospermic men, 1-7%
of severely oligozoospermic men, and 5% of men
with severe primary testicular failure and with
a sperm density of less than 5 million/ml showed
Yq microdeletion [5]. On the basis of selection
criteria of the patients, the rate in the infertile
population is in the range 1-55% [6, 7]. The
difference in Yq microdeletion type and their
frequency in different reports may reflect variations
in the sample group and selection of specific
sequence tagged site (STS) markers [8]. Ordinary
clinical parameters, such as hormone level,
testicular volume, cryptorchidism and infections do
not have an estimated value [9, 10].
Men who have varicocele and a sperm count less
than 5 million/ml must be evaluated for presence
of genetic abnormalities because they appear to
have a poorer response to varicocele repair than
men without coexisting genetic lesions [4].
In this study we aimed to: determine the Yq
microdeletion prevalence among men with
varicocele-related subfertility; compare the cost-
effectiveness of detection analysis and varicocele
repair in the presence of exceptional patients who
have mild semen disorders, and beware of
unnecessary varicocelectomies and consequently
to avoid prolonged treatment of subfertility;
ascertain whether patients with clinical varicocele
should undergo Yq microdeletion analysis as
a routine procedure.
Material and methods
The medical records of 51 consecutive men with
subfertility and clinical palpable varicocele who had
been admitted to our clinic between September
2006 and October 2008 were reviewed. All patients
were primary subfertile and had at least a 1-year
history with the current partner. Males with
normozoospermia, subclinical varicocele, secondary
infertility and having additional female factors in
the aetiologies were excluded from the study.
These men were subjected to comprehensive
questionnaires related to their medical, surgical,
sexual and family histories, and lifestyle habits.
Furthermore, a comprehensive systemic urogenital
examination was performed. Varicocele examination
was performed on the patient in a seated position or
standing erect prior to and after the Valsalva
manoeuvre and was categorized as grade 1 (palpable
only during the manoeuvre), grade 2 (palpable
without the Valsalva manoeuvre) or grade 3 (dilated
veins visible) [11]. Bilateral varicocele was observed in
3 of 51 patients. Preoperative varicocele grades were
1 in 16 patients, 2 in 15 patients and 3 in 17 patients
with left unilateral disease. In the patients with
bilateral varicocele, grades were 1 in 2 patients and 
3 in 1 patient on the left side and 1 in 2 patients and
2 in 1 patient on the right side. Colour-Doppler
ultrasound (CDU) was performed to detect refluxes
and to confirm varicocele diagnosis. To define
a varicocele detected ultrasonographically, we used
a 2 mm cut-off for vein diameter and prolonged reflux
longer than 1 s [12]. At least 3 semen samples were
obtained from each patient at least 2 weeks apart
and following sexual abstinence for 2-5 days. Sperm
concentration and motility were assessed according
to the WHO criteria [13] and sperm morphology was
assessed according to Kruger’s strict criteria [14] in
the same andrology laboratory in a blind fashion.
After cytogenetic examination, Yq microdeletion
analysis was performed on the peripheral blood
samples collected from 51 patients, using Promega
Y-Chromosome Deletion Detection System Version
2.0 (Promega Corporation–2800 Woods Hollow
Road–Madison, WI 53711 USA). This system
provides a rapid method for detecting deletions that
occur in YqAZF, consisting of 20 primer pairs that
are homologous to previously identified and
mapped STS [8]. These primers amplify non-
polymorphic short DNA segments from the Yq
when used in polymerase chain reactions (PCR).
This makes it possible to determine the presence
or absence of all STS by performing 5 parallel PCR
amplifications. Yq deletions in the regions that are
amplified by these primer sets have been
associated with male infertility [15, 16]. 
Four of the Multiplex Master Mix sets (A-D)
contain a control primer pair that amplifies
a fragment of the X-linked SMCX locus. The fifth
Multiplex Master Mix set (E) contains a primer pair
that amplifies a unique region in both male and
female DNA (ZFX/ZFY). These control primer pairs
are internal controls for the amplification reaction
and the integrity of the genomic DNA sample.
Finally, Multiplex E includes a primer pair that
amplifies a region of the SRY gene. This is a control
for the testis determining factor on the short arm
of the Yq and allows XX males arising from Y to X
translocations to be detected. 
Varicocele repair was performed under general
anaesthesia with optical magnification (3-fold)
through a subinguinal approach preserving the
arteries and lymphatics.
Informed written consent was obtained from
each subject. After a thorough clinical evaluation,
a respective diagnosis of subfertility was given to
each individual accordingly and genetic counselling
has been provided to the patients. This research
was conducted in accordance with the Helsinki
Declaration principles.
Results
The mean age of the patients was 27.9 years 
(18-38 years). The sperm concentration ranged from
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0 to 72 million/ml, the motility (A + B) from 0 to 65%
and Kruger from 0% to 18%. In physical examination,
bilateral testes were of normal size and consistency
and after the Valsalva manoeuvre the mean vein
diameter changed from 2.37 ±0.54 to 2.79 ±0.58
according to the rest position in CDU. The category
and rate of patients according to seminal analysis
are summarized in Table I. All patients were
cytogenetically normal. In our patient cohort of 
51 individuals, Yq microdeletion was detected in 
2 patients (3.92%). The first patient was 24 years
old and had grade 1 varicocele with reflux on the left
side. Values of semen volume (ml), sperm
concentration (million/ml), motility (A + B) and
Kruger were 3.5, 15, 25 + 19 and 2, respectively. There
were no pathologies in cytogenetic examination
(Figure 1A). However, microdeletion was detected in
sY121 of the AZFb region of the Y chromosome
(Figure 1B). The second patient was 23 years old and
had grade 1 varicocele on the left side. The semen
volume was 2 ml and there was only one sperm in
each microscope area. No pathologies were detected
in cytogenetic examination (Figure 2A). Micro  -
deletions were present in sY254 and sY255 in the
AZFc region of the Y chromosome (Figure 2B).
Varicocelectomy was applied to all patients
except for those two 2 patients who had partial AZF
deletions.
Discussion
The first cases of Yq microdeletions and male
infertility were reported in 1992 [17] and many case
series have subsequently been published. Yq
Patient classification n %
Azoospermia 4 7.8
Oligoasthenoteratozoospermia (OAT) 15 29.4
Oligoteratozoospermia 5 9.8
Oligoasthenozoospermia 2 3.9
Asthenoteratozoospermia 11 21.6
Asthenozoospermia 1 2.0
Teratozoospermia 13 25.5
Total 51 100
Table I. Preliminary clinical data of semen parameters
in accordance with WHO criteria and Kruger’s strict
criteria
Figure 1. The patient who had a deletion on the AZFb region, sY121 locus: A – cytogenetic formation, B – Yq map
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microdeletions play a role in 0.3-7% of infertile cases
in connection with the male factor and this rate is
higher in a selected population with severe seminal
parameter disorder [6, 7, 16]. In Yq microdeletion
cases, AZFc region deletion is the highest group
with 60%, followed by AZFb, AZFbc, AZFa and AZFa
+ b + c at 16%, 8%, 5% and 4%, respectively. 
The deletion of the AZFa region in clinical cases
causes mostly azoospermia, whereas the deletions
of AZFb and AZFc regions mostly cause oligozo  -
ospermia or teratozoospermia [16, 18, 19]. 
In non-obstructive azoospermia cases with
deletions in the AZFa region, until today, no sperm
could be found even with testicular sperm
extraction (TESE [20, 21]). If the deletion in the AZFb
region is sufficiently large, this may cause
azoospermia and again the chance of finding sperm
even with TESE is very slim. While there is a chance
to provide sperm with TESE in partial AZFb
deletions, in almost half of the cases, the chance
of presence of mature spermatozoa is almost non-
existent in cases with complete AZFb deletion [22].
In azoospermic males with AZFa and AZFb deletion,
although successful results during sperm collection
with TESE have been obtained, in 38% of infertile
males with deletion in the AZFc region, sperm has
been detected with sperm analysis [20].
Varicocele has been detected in 25% of those
males who have anomalous seminal parameters
[23]. There is a high incidence of chromosomal
defects in severely oligozoospermic men compared
with mildly oligozoospermic men among men with
varicocele-related infertility, idiopathic infertility and
overall male infertility, which is not the same in the
case of Yq microdeletions. There was no significant
difference in the cumulative frequencies of Yq
Figure 2. The patient who had deletions on the AZFc region, sY254 and sY255 locus: A – cytogenetic formation, 
B – Yq map
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microdeletions in individuals with varicocele and
idiopathic infertility. No correlation was seen
between the sperm concentration and the size or
the extent of the microdeletions [24].
In very few of the many studies dealing with Yq
deletion have patients with varicocele been
included or, in general, have patient populations
with azoospermia and severe oligozoospermia been
evaluated [25, 26]. Moro et al. did not detect any
deletions in a patient group of 80 individuals with
varicocele and mild oligozoospermia, but they
reported 17.5% Yq microdeletion in the second
patient group consisting of 40 individuals with
severe oligozoospermia and idiopathic infertility
[27]. Rao et al. found Yq microdeletion in 3 of 
57 patients (5.26%) with non-idiopathic infertility.
Of these patients 1 has been diagnosed with
azoospermia, another 1 with mild oligozoospermia,
and the last 1 with severe oligozoospermia [24].
Dada  et al. observed microdeletion in 7 of 
72 infertile patients (9.7%) with varicocele; 4 of
these patients were diagnosed with azoospermia
and 3 with severe oligozoospermia [28].
Numerous studies have emphasized that the
performance of Yq microdeletion analysis for
varicocele patients, diagnosed with azoospermia
and severe oligozoospermia (having sperm
concentrations lower than 5 million/ml), was
important as a diagnostic and prognostic factor [10,
25-28]. In this study, we included patients who had
applied to our clinic with the complaint of
subfertility and who had been diagnosed with
clinical varicocele. We did not eliminate mild
oligozoospermic patients (sperm count 5-20
million/ml). In our patient cohort of 51 individuals,
Yq microdeletion was detected in only 2 patients.
In our first patient with mild oligoteratozoospermia,
partial AZFb deletion (sY121) and in our second
patient with severe oligozoospermia, partial AZFc
deletion (sY254 and sY255) were detected and
according to best practice guidelines [29] for Yq
microdeletion studies when both markers of sY254
and sY255 were deleted, a diagnosis of complete
deletion of the AZFc region could be made.
Moreover, the literature suggests that patients with
varicocele and genetic infertility do not benefit from
varicocelectomy [4, 25]. These 2 patients were
consequently not subjected to varicocelectomy.
In most andrology and infertility centres in
Turkey and abroad, the Yq microdeletion assay is
performed for infertile males whose sperm density
is below 5 million/ml. This is an essential
prerequisite for infertile men undergoing
intracytoplasmic sperm injection (ICSI) to rule out
the possibility of transmission of the same deletions
to their male offspring, who could also experience
infertility. This fact is also significant because these
men are at an increased risk for having recurrent
miscarriages with their partner, and children with
birth defects and learning disabilities.
To enable decision-making, patients need to be
informed about the tests. If testing is performed
and an abnormality is identified, professional
genetic counselling should be offered, where
patients are provided with an explanation of the
cause of the genetic defect they have been
identified with by a geneticist. More importantly,
the consequences for the person tested, his future
children and his family members are discussed and,
if necessary, further counselling and testing for
other family members is organised. Following the
explanations made to the families, approximately
21% of couples with microdeletions have given up
ICSI [30].
The package cost of Yq microdeletion analysis
in our country is approximately $470. The cost of
single-sided varicocelectomy with optical magni  -
fication to the Social Security Institution is
approximately $500. According to our data, since
the rate of Yq microdeletion, in our cohort,
consisting of patients with subfertility and clinical
varicocele, is low (3.92%), routine performance of
this analysis in such a patient population did not
appear to be cost-effective. However, in our patient
cohort, since Yq microdeletion was determined in
1 patient with mild oligozoospermia, as reported in
the study of Rao et al. [24], but different from many
studies [25-28], the failure to perform this analysis
will cause the patient to fail to obtain genetic
counselling and subject them to an unnecessary
surgical procedure. However, considering our cohort
of 51 patients and the other studies mentioned
above, cohorts of sufficient size to recommend this
analysis as a routine procedure prior to varico  -
celectomy do not exist. 
In conclusion, Yq microdeletions contribute only
marginally to the totality of human male infertility,
but when present, the introduction of ICSI as an
artificial reproductive technique (ART) may allow
for the transmission of such mutations to the next
generation [31]. Our data suggest that the routine
performance of Yq microdeletion analysis in
patients with clinical varicocele does not appear to
be cost-effective, but there are several consider  -
ations that support a routine assessment 
of Yq deletions. Firstly, a positive test would provide
a firm diagnosis of the man’s problem, which, for
some couples with longstanding infertility, can help
resolve stress, blame or feelings of guilt. Secondly,
knowledge of the type of Yq deletion may assist
the clinician in determining the best type of ART
treatment. Thirdly, couples should be offered this
information, as they must understand that their
male offspring will almost certainly be subfertile
and require reproductive monitoring from the time
of sexual maturation. However, as stated in the
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literature, most genetic defects have been found in
patients with azoospermia or sperm concentrations
of 5 million/ml or lower and the assay was
suggested for application only to this group of
patients, but our findings support that the omission
of patients with mild oligozoospermia would have
subjected them to an unnecessary varicocelectomy
and/or further ICSI applications and also would
have caused the failure of referral for genetic
counselling. Within this framework, large-scale
studies are needed.
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